生物活性检测方法验证专栏

生物活性检测方法的验证实验设计探讨*

展开
  • 1.中国食品药品检定研究院 国家药品监督管理局化学药品质量研究与评价重点实验室,北京 102629;
    2.北京民海生物科技有限公司,北京 102629
第一作者 Tel:(010) 53851589;E-mail:tandj@nifdc.org.cn

收稿日期: 2022-04-18

  网络出版日期: 2024-06-24

基金资助

* 国家药品标准制修订课题(2022Y09);中检院质量安全与能力建设项目

Discussion on the experiment design of bioassay validation*

Expand
  • 1. NMPA Key Lab for Quality Research and Evaluation of Chemical Drug, National Institutes for Food and Drug Control, Beijing102629, China;
    2. Beijing Minhai Biotechnology Co., Ltd., Beijing 102629, China

Received date: 2022-04-18

  Online published: 2024-06-24

摘要

科学的实验设计是保证检测方法的结果准确性和结论可靠性的主要工具。本文对影响因素多且变异大的生物活性检测方法验证所需的实验设计进行了探讨,并详细阐述了在方法验证设计中样本量的计算方法。希望今后能为生物活性检测方法验证人员准确理解方法验证实验设计提供理论参考。

本文引用格式

谭德讲, 段丽, 耿颖, 韩璐, 李娜, 杜颖 . 生物活性检测方法的验证实验设计探讨*[J]. 药物分析杂志, 2022 , 42(6) : 962 -965 . DOI: 10.16155/j.0254-1793.2022.06.07

Abstract

Scientific design of experiment (DOE) is the main tool to ensure the accuracy of test results and the reliability of conclusions. It is discussed the validation design for bioassay with many influencing factors and great variation, and the calculation method of sample size in method validation design is elaborated in detail here. It is hoped that it could provide theoretical reference for bioassay valiadation to accurately understand the experimental design of method validation.

参考文献

[1] ISO 9000:2015 Quality Management Systems-Fundamentals and Vocabulary[S].2015
[2] USP <1220> Analytical Procedure Life Cycle[S/OL].2022. (2022-05-18) https://doi.org/10.31003/USPNF_M10975_02_01
[3] 谭德讲, 马双成. 药品监督与检定中的统计学应用[M].北京:中国科学技术出版社, 2011: 52, 132
TAN DJ, MA SC. Statistical Applications in Biopharmaceutical Regulatory Science [M].Beijing: China Science and Technology Press, 2011: 52, 132
[4] 朱容蝶, 耿颖, 谭德讲, 等. 方法验证性能参数的获取和评价方式再探讨[J].药物分析杂志, 2019, 39(2): 202
ZHU RD, GENG Y, TAN DJ,et al. Further discussion about the acquisition and evaluation of performance parameters in procedure validation[J].Chin J Pharm Anal, 2019, 39(2): 202
[5] USP 43-NF 38[S].2020: 7320, 7337, 8117
[6] ICH Q2 (R1). Validation of Analytical Procedure: Text and Methodology[S/OL]. 2005. (2022-02-03) https://www.ich.org/page/quality-guidelines
[7] 中华人民共和国药典2020年版. 四部[S].2020:480, 530
ChP 2020 .Vol Ⅳ[S].2020: 480, 530
[8] 马莉, 杨亚宗, 张云雷, 等. 含量测定类方法验证中的统计学评价[J].药物分析杂志, 2019, 39(2):207
MA L, YANG YZ, ZHANG YL,et al. Statistical evaluation of method validation for content determination[J].Chin J Pharm Anal, 2019, 39(2): 207
[9] 朱容蝶, 耿颖, 谭德讲, 等. 杂质类定量分析方法验证中的统计学评价[J].药物分析杂志, 2019, 39(2):215
ZHU RD, GENG Y, TAN DJ,et al. Statistical evaluation of method validation for quantitation of impurities[J].Chin J Pharm Anal, 2019, 39(2): 215
[10] 段丽, 韩璐, 杜颖, 等. 方法满足预期用途的评估指标和标准探讨[J].药物分析杂志. 2022, 42(6):966
DUAN L, HAN L, DU Y,et al. Discussion about the evaluation indexes and criteria of assay for satisfying its intended use [J].Chin J Pharm Anal, 2022, 42(6):966
[11] 谭德讲, 朱容蝶, 耿颖, 等.判断定量类理化分析方法满足预期用途的标准探讨[J].药物分析杂志, 2019, 39(2):196
TAN DJ, ZHU RD, GENG Y,et al. Discussion about the criteria of quantitative physicochemical analytical methods for satisfying their intended use[J].Chin J Pharm Anal, 2019, 39(2): 196
[12] 段丽, 韩璐, 杜颖, 等. 方法验证数据集的应用探讨[J].药物分析杂志, 2022, 42(6):972
DUAN L, HAN L, DU Y,et al. Discussion on the application of method validation data set [J].Chin J Pharm Anal, 2022, 42(6):972
文章导航

/